Tags

Type your tag names separated by a space and hit enter

Traditional kava beverage consumption and liver function tests in a predominantly Tongan population in Hawaii.
Clin Toxicol (Phila) 2007 Jun-Aug; 45(5):549-56CT

Abstract

PURPOSE

To determine the effects of traditionally prepared kava beverages on the liver function tests of regular kava beverage consumers in a population of Tongan and non-Tongan residents of Hawaii (Oahu).

METHODS

The liver function tests of 31 healthy adult kava drinkers were compared against a control group of 31 healthy adult non-kava drinkers. Subjects were recruited from the general population, a kava bar, and Tongan kava drinking circles. The liver function profile included AST, ALT, ALP, GGT, and bilirubin (total and direct). Other tests included total protein, albumin, and screens for viral hepatitis and hemochromatosis when indicated.

RESULTS

Chronic kava beverage consumption was associated with elevation of GGT in 65% of the kava drinkers versus 26% in the controls (P = .005). ALP was elevated in 23% of kava drinkers versus 3% in the controls (P = .053).

CONCLUSION

Heavy kava beverage consumption was associated with significantly elevated GGT levels.

Authors+Show Affiliations

Department of Complementary & Alternative Medicine, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, Hawaii, USA. amybrown@hawaii.eduNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, N.I.H., Extramural

Language

eng

PubMed ID

17503265

Citation

Brown, Amy C., et al. "Traditional Kava Beverage Consumption and Liver Function Tests in a Predominantly Tongan Population in Hawaii." Clinical Toxicology (Philadelphia, Pa.), vol. 45, no. 5, 2007, pp. 549-56.
Brown AC, Onopa J, Holck P, et al. Traditional kava beverage consumption and liver function tests in a predominantly Tongan population in Hawaii. Clin Toxicol (Phila). 2007;45(5):549-56.
Brown, A. C., Onopa, J., Holck, P., Kaufusi, P., Kabasawa, D., Craig, W. J., ... Baker, J. D. (2007). Traditional kava beverage consumption and liver function tests in a predominantly Tongan population in Hawaii. Clinical Toxicology (Philadelphia, Pa.), 45(5), pp. 549-56.
Brown AC, et al. Traditional Kava Beverage Consumption and Liver Function Tests in a Predominantly Tongan Population in Hawaii. Clin Toxicol (Phila). 2007;45(5):549-56. PubMed PMID: 17503265.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Traditional kava beverage consumption and liver function tests in a predominantly Tongan population in Hawaii. AU - Brown,Amy C, AU - Onopa,Janet, AU - Holck,Peter, AU - Kaufusi,Pakieli, AU - Kabasawa,Derek, AU - Craig,Winston J, AU - Dragull,Klaus, AU - Levine,Arieh M, AU - Baker,Jonathan D, PY - 2007/5/16/pubmed PY - 2007/7/31/medline PY - 2007/5/16/entrez SP - 549 EP - 56 JF - Clinical toxicology (Philadelphia, Pa.) JO - Clin Toxicol (Phila) VL - 45 IS - 5 N2 - PURPOSE: To determine the effects of traditionally prepared kava beverages on the liver function tests of regular kava beverage consumers in a population of Tongan and non-Tongan residents of Hawaii (Oahu). METHODS: The liver function tests of 31 healthy adult kava drinkers were compared against a control group of 31 healthy adult non-kava drinkers. Subjects were recruited from the general population, a kava bar, and Tongan kava drinking circles. The liver function profile included AST, ALT, ALP, GGT, and bilirubin (total and direct). Other tests included total protein, albumin, and screens for viral hepatitis and hemochromatosis when indicated. RESULTS: Chronic kava beverage consumption was associated with elevation of GGT in 65% of the kava drinkers versus 26% in the controls (P = .005). ALP was elevated in 23% of kava drinkers versus 3% in the controls (P = .053). CONCLUSION: Heavy kava beverage consumption was associated with significantly elevated GGT levels. SN - 1556-3650 UR - https://www.unboundmedicine.com/medline/citation/17503265/full_citation L2 - http://www.tandfonline.com/doi/full/10.1080/15563650701365875 DB - PRIME DP - Unbound Medicine ER -